Exploring the Perspectives and Experiences of PrEP-eligible Black Women in Texas in Relation to R… (NCT05530993) | Clinical Trial Compass
CompletedNot Applicable
Exploring the Perspectives and Experiences of PrEP-eligible Black Women in Texas in Relation to Readiness for PrEP Uptake and Adherence
United States20 participantsStarted 2023-02-01
Plain-language summary
The aim is to conduct two virtual focus groups (10 participants in each group) with 20 pre-exposure prophylaxis (PrEP)-eligible Black women in Houston and Austin, TX. Participants will be assigned to focus groups with other women based on their position about PrEP uptake (considered use versus not considered use). Focus group questions will build on an ecologic model framework to inquire about participant's intrapersonal, interpersonal, and community-level factors that influence access to and use of HIV prevention services. This strategy aims to examine potential barriers to PrEP uptake among PrEP-eligible women in two Texas' hotspots.
Who can participate
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* assigned female sex at birth
* identify as Black or African American
* 18 years of age or older
* have had condomless sex with a cisgender man within the past 12 months
* fluent in English or Spanish
* have a phone or internet access
* not currently on PrEP and have never taken PrEP
Exclusion Criteria:
* choose not to identify as Black or African American
* unable to provide informed consent for participation (e.g. have severe cognitive impairment that would interfere with their ability to consent)
* have psychological distress that would prohibit them from participating in the study
* unable or unwilling to meet study requirements
* ineligible for HIV prevention services \[i.e., Human Immunodeficiency Virus (HIV) Positive\]
* received a prescription for PrEP within 12 months
* has a history of PrEP uptake or is currently on PrEP
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Facilitators to readiness to adopt PrEP
Timeframe: during the focus group
2
Barriers to readiness to adopt PrEP
Timeframe: during the focus group
Trial details
NCT IDNCT05530993
SponsorThe University of Texas Health Science Center, Houston